Based on the analysis of technical indicators and recent news sentiment, the predicted stock price for Elevance Health (ELV) for the next trading week is $415.
Buy
The stock is expected to rise due to positive earnings results and strong analyst sentiment, with a mean target price of $485.13, suggesting a potential upside of 22.1%. The stock is trading above its 50-day moving average and shows signs of bullish momentum.
The price of ELV is predicted to go up 2.25%, based on the high correlation periods with TR. The similarity of these two price pattern on the periods is 91.07%.
ELV
TR
Year
ELV Price Forecast($)
Potential Return(%)
2025
371.560
0.000
2026
520.000
31.020
2027
520.000
31.020
2028
550.000
38.580
2029
650.000
63.780
2030
550.000
38.580
Elevance continues to use its scale-related advantages for the benefit of clients, and we remain intrigued by its ongoing efforts to align incentives with caregivers, including the deployment of high performance provider networks.
The company's Carelon services platform, which includes its PBM, should support material savings for clients, higher profitability for Elevance, and the potential to boost growth with cross-selling opportunities.
Management aims for relatively high annualized earnings growth of 12%-15% in the long run.
Barclays
2025-01-24
Price Target
$501 → $512
Upside
+27.69%
Truist Securities
2025-01-06
Price Target
$520 → $480
Upside
+26.43%
Mizuho
2024-11-05
Price Target
$585 → $505
Upside
+20.88%